#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myxofibrosarcoma VEXAS syndrome Hereditary motor and sensory neuropathy Vernal keratoconjunctivitis Waldenstrom's macroglobulinaemia Epilepsy Small cell lung cancer recurrent Rectal cancer Central nervous system neoplasm Myeloproliferative neoplasm Nephropathy Rheumatoid arthritis Waldenstrom's macroglobulinaemia refractory Malignant peritoneal neoplasm Amyotrophic lateral sclerosis gene carrier More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma – Diagnostics Glomerulonephritis membranoproliferative – Trials in Disease Wiskott-Aldrich syndrome – Diagnostics Mucous membrane pemphigoid Idiopathic pulmonary fibrosis – Diagnostics Advanced systemic mastocytosis – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Combined immunodeficiency – Treatment Mantle cell lymphoma – Basic Information Lysosomal storage disorder – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tryptophan Rbl015.2 Ict01 Desflurane Pitavastatin Calcium RO7288817 Zalunfiban Marstacimab Cefepime Hydrochloride Azd0901 Syn2 Oxygen Ph.eur. Niflumic Acid Esomeprazole ATTR-01 AMODIAQUINE D-Camphor INSULIN DETEMIR Encorafenib Epinephrine More therapies…

    Learn about Your Condition

    Oedema peripheral Mental disorder Anal incontinence Skin neoplasm excision Breast cancer stage I Synovial sarcoma recurrent Cancer pain Shprintzen-Goldberg syndrome Progressive supranuclear palsy Drug eruption Atrophic vulvovaginitis Sepsis Milk allergy Cirrhosis alcoholic EGFR gene mutation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on AP-01 for Patients with Acute Heart Failure (NYHA Class III or Higher)

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure acute
    Germany

  • Study to Compare Zongertinib with Standard Treatment for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Zongertinib
    • Carboplatin
    • Cisplatin
    Austria Belgium France Germany Greece Hungary +7

  • Study on the Safety and Effectiveness of PLX-PAD Cells for Patients with Mild to Moderate Knee Osteoarthritis

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Emiplacel
    • Cetirizine Dihydrochloride
    Germany

  • Study of INCB099280 and Adagrasib for Adults with Advanced Solid Tumors with KRASG12C Mutation

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Incb099280
    • Adagrasib
    France Italy Spain

  • Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Deucravacitinib
    • Jnj-77242113
    Germany Hungary Italy Poland Romania Spain

  • Study on Temporarily Stopping Duloxetine, Sertraline, and Paroxetine in Patients with Hip or Knee Osteoarthritis Undergoing Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hip arthroplasty
    • Knee arthroplasty
    Investigated Drugs:
    • Citalopram
    • Citalopram Hydrobromide
    • Duloxetine
    Denmark
Previous Page
1 … 855 856 857 858 859 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!